Medical News

RSS

CytRx commences PROACT Phase 2 clinical trial of bafetinib for advanced prostate cancer

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced initiation of the PROstate Advanced Cancer Treatment (PROACT) Phase 2 proof-of-concept clinical trial to evaluate the efficacy and safety of bafetinib in patients with advanced prostate cancer.

7 Sep 2010

Promedior initiates PRM-151 Phase 2a clinical study in prevention of scarring post glaucoma filtration surgery

Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today that it has initiated a Phase 2a clinical study of PRM-151 to evaluate the efficacy, safety, and tolerability of PRM-151 in preventing post-surgical scarring in glaucoma patients following glaucoma filtration surgery. There currently are no approved drugs for preventing post-surgical scarring in glaucoma, and there are no approved anti-fibrotic drug therapies in the U.S. or Europe for any fibrotic disease.

7 Sep 2010

KHN column: Social Security's Disabled Adult Child program: A key program often below the radar

In this Kaiser Health News column, Harold Pollack writes: "Intellectual disability is often accompanied by costly illnesses and social service needs.

7 Sep 2010

TSO3 engaged in regulatory discussions for refiling of new generation sterilizer's 510(k) clearance

TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, today announced that the Company is having productive discussions with US regulators, including a very recent face-to-face meeting. The Company is actively engaged in the changing US regulatory process intended to lead to the refilling for 510(k) clearance on its new generation sterilizer.

7 Sep 2010

Health 2.0 Developer Challenge: Teams are putting final touches on their applications

With only a few weeks left until the deadlines of the Health 2.0 Developer Challenge more than 40 teams are putting the final touches on their applications for the 10 prizes. Winners will be announced by Todd Park, CTO of U.S. Dept. of Health and Human Services (HHS), and Aneesh Chopra, Federal CTO, at the Health 2.0 Conference on October 7-8, in San Francisco.

7 Sep 2010

Lionsgate, Jane Fonda enter deal to improve high-profile fitness

Reflecting an overall strategy of allying itself with world-class, brand name partners in all of its businesses, LIONSGATE, the leading next generation studio, has entered into a home entertainment distribution deal with Jane Fonda, the two time Academy Award winning actress and fitness pioneer who first coined the term "workout" in the 1980s.

7 Sep 2010

Positive immune responses elicited from Scancell's DNA vaccine in combination with ImmuneRegen's Homspera

Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.

7 Sep 2010

Nassau University Medical Center to include Streamline Health Solutions' HIM Suite of workflows

Streamline Health Solutions, Inc. a leading provider of document workflow solutions for hospitals, today announced that Nassau University Medical Center in East Meadow, New York, will expand its software licensing arrangement to include Streamline Health's Enterprise Health Information Management Suite of workflows.

7 Sep 2010

Tiger Balm sponsors Susan G. Komen NYC Race for the Cure to help raise awareness on breast cancer

Tiger Balm announced today its sponsorship of the 20th annual Susan G. Komen NYC Race for the Cure, taking place Sunday, September 12, 2010 in New York's Central Park.

7 Sep 2010

AuthenTec, UPEK combine to expand fingerprint sensors and identity management software

AuthenTec, a leading provider of security, identity management and touch control solutions, and privately-held UPEK, a leading supplier of fingerprint solutions for consumer, business and government applications, announced that the companies have combined, creating the world's largest provider of fingerprint sensors and identity management software, as well as biometric and embedded security solutions.

7 Sep 2010

Bruker launches Icon desktop MRI systems at 2010 World Molecular Imaging Congress

At the 2010 World Molecular Imaging Congress in Kyoto, Bruker Corporation today announces the introduction of the Icon™, a new easy-to-use 1 Tesla desktop MRI scanner that combines simplicity with compact dimensions, in order to bring preclinical magnetic resonance imaging (MRI) within reach for a broader range of molecular imaging laboratories.

7 Sep 2010

Idenix Pharmaceuticals receives clinical hold order from FDA for IDX184, IDX320 programs

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that the company received verbal notice on Friday, September 3, 2010 from the U.S. Food and Drug Administration (FDA) that the IDX184 and IDX320 programs have been placed on clinical hold.

7 Sep 2010

Bend Research expands hot-melt extrusion pharmaceutical manufacturing capabilities

Bend Research Inc., a leading independent drug-formulation development and manufacturing company, announced today that it is expanding its pharmaceutical manufacturing capabilities for hot-melt extrusion.

7 Sep 2010

University of Maryland School of Medicine orders AVANCE III 950 US2 NMR spectrometer from Bruker

Bruker Corporation announces a major order from the University of Maryland School of Medicine for its ultra-high field AVANCE III 950 US2 NMR spectrometer. The 950 MHz Nuclear Magnetic Resonance magnet and spectrometer will help University of Maryland researchers to unravel the mysteries of molecules and develop new agents to treat cancer, AIDS and other diseases.

7 Sep 2010

miacom diagnostics presents rapid detection method for pneumonia causing pathogens

miacom diagnostics specializes on the development and production of medical tests for the detection of acute infectious diseases. In addition to its existing sepsis kits miacom, diagnostics is now presenting a further CE-marked product based on the same proprietary technology. It is targeted at the rapid detection of clinically most relevant pneumonia causing pathogens.

7 Sep 2010

Bruker announces NIST order for AVANCE III 900 NMR spectrometer

Bruker Corporation, the leader in analytical magnetic resonance instrumentation, today announces a major order from the National Institute of Standards and Technology (NIST) for its ultra-high field AVANCE™ III 900 US2 NMR spectrometer.

7 Sep 2010

Water Pik launches first line of sinus wash products

Today, Water Pik, Inc., a global leader in personal healthcare products, announced the launch of its first line of sinus wash products, Waterpik SinuSense. A brand new category for Water Pik, the SinuSense™ name introduces four products to the brand's portfolio, including the Squeeze Bottle, Neti Pot, Neti Bottle and the Water Pulsator - the first and only products of their kind in this category.

7 Sep 2010

Medicare will experiment with expansion of hospice coverage

In this Kaiser Health News consumer column, Michelle Andrews writes: "Many people may not realize that, in some ways, the new health law will expand options for patients at the end of life.

7 Sep 2010

TenX Biopharma recommences enrollment in suspended Phase III trial for cutaneous T-cell lymphoma

TenX Biopharma, Inc. announced today that it has re-initiated enrollment in the pivotal Phase III clinical trial assessing zanolimumab treatment for cutaneous T-cell lymphoma (CTCL) patients (ClinicalTrials.gov identifier: NCT00127881). The trial enrollment was suspended in October 2008 while Genmab was seeking a out-license agreement to further develop the compound. TenX Biopharma acquired global rights to zanolimumab in February, 2010 from Genmab.

7 Sep 2010

Sometimes a hospital stay does not mean you’re admitted

This Kaiser Health News story by Susan Jaffe, produced in partnership with The Washington Post, looks at an increasing use of hospital observation care for Medicare beneficiaries rather than admission as an inpatient.

7 Sep 2010

Medical News

CytRx commences PROACT Phase 2 clinical trial of bafetinib for advanced prostate cancer

Promedior initiates PRM-151 Phase 2a clinical study in prevention of scarring post glaucoma filtration surgery

KHN column: Social Security's Disabled Adult Child program: A key program often below the radar

TSO3 engaged in regulatory discussions for refiling of new generation sterilizer's 510(k) clearance

Health 2.0 Developer Challenge: Teams are putting final touches on their applications

Lionsgate, Jane Fonda enter deal to improve high-profile fitness

Positive immune responses elicited from Scancell's DNA vaccine in combination with ImmuneRegen's Homspera

Nassau University Medical Center to include Streamline Health Solutions' HIM Suite of workflows

Tiger Balm sponsors Susan G. Komen NYC Race for the Cure to help raise awareness on breast cancer

AuthenTec, UPEK combine to expand fingerprint sensors and identity management software

Bruker launches Icon desktop MRI systems at 2010 World Molecular Imaging Congress

Idenix Pharmaceuticals receives clinical hold order from FDA for IDX184, IDX320 programs

Bend Research expands hot-melt extrusion pharmaceutical manufacturing capabilities

University of Maryland School of Medicine orders AVANCE III 950 US2 NMR spectrometer from Bruker

miacom diagnostics presents rapid detection method for pneumonia causing pathogens

Bruker announces NIST order for AVANCE III 900 NMR spectrometer

Water Pik launches first line of sinus wash products

Medicare will experiment with expansion of hospice coverage

TenX Biopharma recommences enrollment in suspended Phase III trial for cutaneous T-cell lymphoma

Sometimes a hospital stay does not mean you’re admitted

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News